Oleander Medical Technologies
Baton Rouge, US · Louisiana LLC
Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 2 rounds · 2017–2024
▶$500KraisedJul 2024 · 4 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paige R. MillerExecutive Officer
- Harry J Gould IIIExecutive Officer
- Henry J. MillsExecutive Officer
- Dennis PaulExecutive Officer
- Offering amount
- $5M
- Amount sold
- $500K
- Minimum investment
- $50K
- First sale
- Jun 2024
- Incorporated
- Limited Liability Company, Louisiana
- Federal exemptions
- 06b
▶$2.2MraisedSep 2020 · 19 investors · BiotechnologyRule 506(b)
▶$2.2MraisedSep 2020 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Henry J MillsExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2.2M
- Minimum investment
- $50K
- First sale
- Jan 2017
- Incorporated
- Limited Liability Company, Louisiana
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Oleander Medical Technologies do?
- Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
- How much funding has Oleander Medical Technologies raised?
- Oleander Medical Technologies has disclosed $2.7M raised across 2 rounds.
- Where is Oleander Medical Technologies headquartered?
- Oleander Medical Technologies is headquartered in Baton Rouge, US.